*The Endocannabinoid System as a Potential Therapeutic Target for Amyotrophic Lateral Sclerosis DOI: http://dx.doi.org/10.5772/intechopen.114388*

including other groups of patients suffering from similar symptoms in the course of other neurological diseases, most commonly in multiple sclerosis (MS) patients. Moreover, there is increasing evidence that cannabinoid compounds may exert neuroprotective effects and prolong the survival in the animal models of ALS. Therefore, larger RTCs are urgently needed to confirm the therapeutic potential of cannabis in slowing down the disease progression.
